Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers

Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoi...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical nutrition Vol. 65; no. 1; pp. 63 - 69
Main Authors Mahalingam, D, Radhakrishnan, A.K, Amom, Z, Ibrahim, N, Nesaretnam, K
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2011
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0954-3007
1476-5640
1476-5640
DOI10.1038/ejcn.2010.184

Cover

Abstract Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. Results: The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P<0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P<0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P<0.05) augmented in the TRF-supplemented group compared with the placebo group. Conclusions: We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.
AbstractList Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. Results: The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P<0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P<0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P<0.05) augmented in the TRF-supplemented group compared with the placebo group. Conclusions: We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines. [PUBLICATION ABSTRACT]
Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. European Journal of Clinical Nutrition (2011) 65, 63-69; doi: 10.1038/ejcn.2010.184; published online 22 September 2010
Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. Results: The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly ( P <0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly ( P <0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly ( P <0.05) augmented in the TRF-supplemented group compared with the placebo group. Conclusions: We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.
Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. Results: The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P<0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P<0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P<0.05) augmented in the TRF-supplemented group compared with the placebo group. Conclusions: We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.
Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P < 0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P < 0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P < 0.05) augmented in the TRF-supplemented group compared with the placebo group. We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.
Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers. Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. Results: The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P<0.05) enhanced production of interferon-g and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P<0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P<0.05) augmented in the TRF-supplemented group compared with the placebo group. Conclusions: We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines. European Journal of Clinical Nutrition (2011) 65, 63-69; doi: 10.1038/ejcn.2010.184; published online 22 September 2010 Keywords: tocotrienol-rich fraction; tetanus toxoid; immunostimulatory
Background/Objectives:Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers.Subjects/Methods:In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly. Results:The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P<0.05) enhanced production of interferon- gamma and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P<0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P<0.05) augmented in the TRF-supplemented group compared with the placebo group. Conclusions:We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.
Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers.BACKGROUND/OBJECTIVESVitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers.In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly.SUBJECTS/METHODSIn this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) supplementation daily. Over the 2-month period of the study, volunteers were asked to attend three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the TT vaccine (20 Lf) intramuscularly.The results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P < 0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P < 0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P < 0.05) augmented in the TRF-supplemented group compared with the placebo group.RESULTSThe results from the clinical trial showed that TRF supplementation significantly increased the total vitamin E level in the plasma of the TRF-supplemented volunteers compared with the placebo group, indicating overall compliance. Volunteers supplemented with TRF showed a significantly (P < 0.05) enhanced production of interferon-γ and interleukin (IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. Volunteers from the TRF group produced significantly (P < 0.05) lower amounts of IL-6 compared with the placebo group. Anti-TT IgG production was also significantly (P < 0.05) augmented in the TRF-supplemented group compared with the placebo group.We conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.CONCLUSIONSWe conclude that TRF has immunostimulatory effects and potential clinical benefits to enhance immune response to vaccines.
Audience Professional
Academic
Author Mahalingam, D
Nesaretnam, K
Radhakrishnan, A.K
Ibrahim, N
Amom, Z
Author_xml – sequence: 1
  fullname: Mahalingam, D
– sequence: 2
  fullname: Radhakrishnan, A.K
– sequence: 3
  fullname: Amom, Z
– sequence: 4
  fullname: Ibrahim, N
– sequence: 5
  fullname: Nesaretnam, K
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23896050$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20859299$$D View this record in MEDLINE/PubMed
BookMark eNqFkktv1DAUhSNURKeFJVuIQMAqg2MnfiyrqjykSiyg68jj3Mx45NjBdoDyC_jZOGRgaDVVFUtJfL9z5etzTrIj6yxk2dMSLUtE-FvYKrvEaPrl1YNsUVaMFjWt0FG2QKKuCoIQO85OQtgilIoMP8qOMeK1wEIssl8XXQcqhtx1eRiHwUAPNsqonc2_67jJo1Mueg3WmcJrtck7L9Wfclq670cLuYcwOBsgwXmEKO0Y0ucPp9uZ0D_nhtrm1vlemnwD0sTNdf7NmdFGAB8eZw87aQI82b1Ps6t3F1_OPxSXn95_PD-7LBQtcSwUFpQzzqqW0ZqpFgtSt2KlGCHVSiFOa4RrqQRpBRKMlpSvlFBd18oWVZRRcpq9mfsO3n0dIcSm10GBMdKCG0PDOU_3Smh5P0kprlhZ4_tJjBkSBKNEvrhFbt3obRp4ggivGJ-O-HKG1tJAo22XDJBqatmc4YqWyceaJao4QK3BgpcmZaTTafsGvzzAp6eFXquDgtf_CWbHQvJrsjLcBJ_thhpXPbTN4HUv_XXzN2UJeLUDZFDSpARZpcOeI1xQVKP9SMq7EDx0_5ASNVPamyntzZT2JqU98eQWr_Sc3TSaNneqdhcRUne7Br_34C7B81nQSdfItU9Hv_qcqgSVAteUEvIbynUZzg
CitedBy_id crossref_primary_10_5650_oleoscience_17_261
crossref_primary_10_1016_j_clnesp_2017_07_004
crossref_primary_10_1017_S0029665111000048
crossref_primary_10_1016_j_freeradbiomed_2014_03_035
crossref_primary_10_1186_1475_2891_10_36
crossref_primary_10_1186_1743_7075_11_52
crossref_primary_10_3389_fphys_2021_751374
crossref_primary_10_4049_jimmunol_1403149
crossref_primary_10_1016_j_jnutbio_2012_08_015
crossref_primary_10_12688_f1000research_137005_1
crossref_primary_10_1002_mnfr_201400521
crossref_primary_10_1111_jpn_12091
crossref_primary_10_3390_ijms17050663
crossref_primary_10_1093_nutrit_nuae108
crossref_primary_10_1128_CVI_00183_13
crossref_primary_10_1093_nutrit_nuae061
crossref_primary_10_3390_molecules27020555
crossref_primary_10_1016_j_crimmu_2021_10_001
crossref_primary_10_3390_antiox10050634
crossref_primary_10_1097_SPC_0b013e32834e3bd7
crossref_primary_10_18697_ajfand_119_21685
crossref_primary_10_1093_ageing_afac328
crossref_primary_10_1371_journal_pone_0057779
crossref_primary_10_3390_molecules27061896
crossref_primary_10_1186_1743_7075_11_5
crossref_primary_10_1007_s11418_019_01323_6
crossref_primary_10_1038_s41526_021_00162_8
crossref_primary_10_1002_iub_1976
crossref_primary_10_1007_s12263_011_0233_y
crossref_primary_10_21518_2079_701X_2022_16_16_101_107
crossref_primary_10_3390_ph16101403
crossref_primary_10_1016_j_semradonc_2018_10_008
crossref_primary_10_3390_ijms17111682
crossref_primary_10_1016_j_drudis_2017_08_001
crossref_primary_10_1016_j_jnutbio_2015_02_011
crossref_primary_10_1016_j_joim_2019_11_005
crossref_primary_10_1002_14651858_CD007176_pub2
crossref_primary_10_1038_s41598_020_73741_6
crossref_primary_10_3390_nu10111614
crossref_primary_10_3945_an_117_016329
crossref_primary_10_1155_2013_782067
crossref_primary_10_1080_14712598_2017_1375096
crossref_primary_10_3390_nu13072320
crossref_primary_10_1016_j_jddst_2022_103752
crossref_primary_10_3109_19390211_2013_822452
Cites_doi 10.1074/jbc.275.17.13049
10.1001/jama.1997.03540410058031
10.1016/S0167-5699(00)01699-6
10.1093/ajcn/71.2.458
10.1007/s11745-006-5119-1
10.1196/annals.1331.014
10.1056/NEJM200001203420302
10.1093/jn/116.4.675
10.1016/0891-5849(92)90166-E
10.1016/0047-6374(86)90034-5
10.3177/jnsv.49.94
10.1093/ajcn/70.5.793
10.1146/annurev.iy.07.040189.001045
10.1046/j.1365-2249.1999.01045.x
10.1093/ajcn/69.6.1273
10.1271/bbb.63.1697
10.1080/096374800111121
10.1079/BJN19970193
10.1093/ajcn/74.6.714
ContentType Journal Article
Copyright Macmillan Publishers Limited 2011
2015 INIST-CNRS
COPYRIGHT 2011 Nature Publishing Group
Copyright Nature Publishing Group Jan 2011
Copyright_xml – notice: Macmillan Publishers Limited 2011
– notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2011 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jan 2011
DBID FBQ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RV
7TK
7X2
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
KB0
LK8
M0K
M0S
M1P
M2O
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7S9
L.6
7QL
7T5
C1K
H94
DOI 10.1038/ejcn.2010.184
DatabaseName AGRIS
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
ProQuest Agricultural Science
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials Local Electronic Collection Information
Biological Science Collection
ProQuest Central
Natural Science Collection (ProQuest)
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Agricultural Science Database
Health & Medical Collection (Alumni Edition)
Medical Database
Research Library
Biological science database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Agricultural & Environmental Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
DatabaseTitleList Agricultural Science Database



AGRICOLA
MEDLINE


AIDS and Cancer Research Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
– sequence: 4
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Diet & Clinical Nutrition
Medicine
Public Health
EISSN 1476-5640
EndPage 69
ExternalDocumentID 2229801021
A246100157
20859299
23896050
10_1038_ejcn_2010_184
US201301925663
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Malaysia
GeographicLocations_xml – name: Malaysia
GroupedDBID ---
-ET
-Q-
.GJ
0R~
29G
2WC
36B
39C
3V.
4.4
406
53G
5GY
5RE
6PF
70F
7RV
7X2
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
A8Z
AADWK
AAIKC
AAMNW
AANZL
AATNV
AAWBL
AAWTL
AAYFA
AAYJO
AAZLF
ABAWZ
ABCQX
ABDBF
ABGIJ
ABJNI
ABLJU
ABOCM
ABPTK
ABUWG
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACKTT
ACMJI
ACPRK
ACRQY
ACTTH
ACVWB
ADBBV
ADFRT
ADHDB
ADHUB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AEVLU
AEXYK
AFKRA
AFNRJ
AFRAH
AFSHS
AGAYW
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AI.
AILAN
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AN0
APEBS
ATCPS
AXYYD
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BKOMP
BNQBC
BPHCQ
BVXVI
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E.L
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBO
EBS
ECGQY
EE.
EHN
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPT
ESTFP
ESX
EX3
F5P
FBQ
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HZ~
IAG
IAO
ICU
IEA
IHR
IHT
IHW
INH
INR
IOF
ITC
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M0K
M1P
M2O
M7P
NADUK
NAO
NAPCQ
NQJWS
NXXTH
NYICJ
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
Q~Q
RNS
RNT
RNTTT
RXW
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
TAE
TAOOD
TBHMF
TDRGL
TEORI
TH9
TR2
TSG
TUS
UKHRP
VH1
WH7
WOW
XOL
ZXP
~02
~8M
~KM
AACDK
AAHBH
AASML
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABRTQ
ABZZP
ACAOD
ACSTC
ACUHS
ACZOJ
AEFQL
AEMSY
AEUYN
AEZWR
AFBBN
AFDZB
AFHIU
AGQEE
AHWEU
AIGIU
AIXLP
ALIPV
ATHPR
AYFIA
EIHBH
FIGPU
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
ROL
SOJ
AAYXX
CITATION
PUEGO
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
ACMFV
AEIIB
7QP
7TK
7XB
8FK
K9.
LK8
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7S9
L.6
7QL
7T5
C1K
H94
ID FETCH-LOGICAL-c612t-c29687874d7657cd2935d9bc7334bc0865025ac93d90976168bc9cffdad046763
IEDL.DBID BENPR
ISSN 0954-3007
1476-5640
IngestDate Tue Oct 07 09:03:20 EDT 2025
Thu Oct 02 11:47:22 EDT 2025
Thu Oct 02 15:00:53 EDT 2025
Fri Oct 03 08:01:53 EDT 2025
Mon Oct 20 22:52:51 EDT 2025
Fri Jun 13 00:02:53 EDT 2025
Mon Oct 20 16:59:26 EDT 2025
Thu May 22 21:24:50 EDT 2025
Mon Jul 21 06:05:26 EDT 2025
Mon Jul 21 09:16:31 EDT 2025
Thu Apr 24 23:06:23 EDT 2025
Wed Oct 01 03:53:43 EDT 2025
Mon Jul 21 06:06:56 EDT 2025
Wed Dec 27 18:43:12 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords immunostimulatory
tetanus toxoid
tocotrienol-rich fraction
Human
Immune response
Vaccination
Volunteer
Metabolic diseases
Infection
Immunostimulant agent
Bacteriosis
Supplementation
Tetanus
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c612t-c29687874d7657cd2935d9bc7334bc0865025ac93d90976168bc9cffdad046763
Notes http://dx.doi.org/10.1038/ejcn.2010.184
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
PMID 20859299
PQID 822384786
PQPubID 33883
PageCount 7
ParticipantIDs proquest_miscellaneous_888103361
proquest_miscellaneous_866247152
proquest_miscellaneous_822709320
proquest_journals_822384786
gale_infotracmisc_A246100157
gale_infotracgeneralonefile_A246100157
gale_infotracacademiconefile_A246100157
gale_healthsolutions_A246100157
pubmed_primary_20859299
pascalfrancis_primary_23896050
crossref_primary_10_1038_ejcn_2010_184
crossref_citationtrail_10_1038_ejcn_2010_184
springer_journals_10_1038_ejcn_2010_184
fao_agris_US201301925663
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-01-01
PublicationDateYYYYMMDD 2011-01-01
PublicationDate_xml – month: 01
  year: 2011
  text: 2011-01-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: Basingstoke
– name: England
PublicationTitle European journal of clinical nutrition
PublicationTitleAbbrev Eur J Clin Nutr
PublicationTitleAlternate Eur J Clin Nutr
PublicationYear 2011
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Alcami, Koszinowski (CR1) 2000; 21
Kappus, Diplock (CR7) 1992; 13
De Waart, Portengen, Doekes, Verwaal, Kok (CR4) 1997; 8
Sen, Kanna, Roy, Packer (CR18) 2000; 275
Gu, Wakizono, Sunada, Hung, Nonaka, Sugano (CR5) 1999; 63
Nesaretnam, Dorasamy, Darbre (CR14) 2000; 51
Kilian, Nielsen (CR8) 1980; 40
Yusuf, Dagenais, Pogue, Bosch, Sleight (CR23) 2000; 342
Sneath, Kerslake, Scruby (CR19) 1987; 25
Nesaretnam, Ambra, Selvaduray, Radhakrishnan, Canali, Virgili (CR13) 2004; 1031
Mosmann, Coffman (CR12) 1989; 7
Park, Kim, Kim, Kim, Kim (CR16) 2003; 49
Meydani, Meydani, Verdon, Shapiro, Blumberg, Hayes (CR10) 1997; 34
Sundram, Gapor (CR20) 1992; 7
Moriguchi, Kobayashi, Kishino (CR11) 1990; 120
Meydani, Meydani, Blumberg, Leka, Siber, Loszewski (CR9) 1997; 277
Radhakrishnan, Lee, Wong, Kaur, Aung, Nesaretnam (CR17) 2008; 101
Tits van, Demacker, Graaf, Hak-Lemmers, Stalenhoef (CR21) 2000; 77
Pallast, Schouten, De Waart, Fonk, Doekes, von Blomberg (CR15) 1999; 69
Vatassery, Bauer, Dysken (CR22) 1999; 70
Yu, Thomas, Gapor, Tan, Qureshi, Qureshi (CR24) 2006; 41
Jiang, Christen, Shigenaga, Ames (CR6) 2001; 74
Bendich, Gabriel, Machlin (CR2) 1986; 116
Bruunsgaard, Pedersen, Schroll, Skinhoj, Pedersen (CR3) 1999; 118
FG De Waart (BFejcn2010184_CR4) 1997; 8
K Nesaretnam (BFejcn2010184_CR14) 2000; 51
EG Pallast (BFejcn2010184_CR15) 1999; 69
K Sundram (BFejcn2010184_CR20) 1992; 7
PAT Sneath (BFejcn2010184_CR19) 1987; 25
TR Mosmann (BFejcn2010184_CR12) 1989; 7
JY Gu (BFejcn2010184_CR5) 1999; 63
A Bendich (BFejcn2010184_CR2) 1986; 116
GT Vatassery (BFejcn2010184_CR22) 1999; 70
S Yusuf (BFejcn2010184_CR23) 2000; 342
S Moriguchi (BFejcn2010184_CR11) 1990; 120
H Bruunsgaard (BFejcn2010184_CR3) 1999; 118
LJ Tits van (BFejcn2010184_CR21) 2000; 77
K Nesaretnam (BFejcn2010184_CR13) 2004; 1031
H Kappus (BFejcn2010184_CR7) 1992; 13
SG Yu (BFejcn2010184_CR24) 2006; 41
A Alcami (BFejcn2010184_CR1) 2000; 21
HD Kilian (BFejcn2010184_CR8) 1980; 40
OJ Park (BFejcn2010184_CR16) 2003; 49
Q Jiang (BFejcn2010184_CR6) 2001; 74
SN Meydani (BFejcn2010184_CR10) 1997; 34
AK Radhakrishnan (BFejcn2010184_CR17) 2008; 101
SN Meydani (BFejcn2010184_CR9) 1997; 277
CK Sen (BFejcn2010184_CR18) 2000; 275
References_xml – volume: 275
  start-page: 13049
  year: 2000
  end-page: 13055
  ident: CR18
  article-title: Molecular basis of Vitamin E action
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.17.13049
– volume: 277
  start-page: 1380
  year: 1997
  end-page: 1386
  ident: CR9
  article-title: Vitamin E supplementation and immune response in healthy elderly subjects. A randomized controlled trial
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.1997.03540410058031
– volume: 101
  start-page: 810
  year: 2008
  end-page: 815
  ident: CR17
  article-title: Comparable effects on immune modulation following daily supplementation with tocotrienol- rich fraction (TRF) or alpha-tocopherol in normal human volunteers
  publication-title: Br JNutr
– volume: 21
  start-page: 447
  year: 2000
  end-page: 455
  ident: CR1
  article-title: Viral mechanisms of immune evasion
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(00)01699-6
– volume: 25
  start-page: 464
  year: 1987
  end-page: 476
  ident: CR19
  article-title: Tetanus immunity: the resistance of guinea pigs to lethal spore doses induced by active and passive immunization
  publication-title: Am J Trop Med Hyg
– volume: 77
  start-page: 458
  year: 2000
  end-page: 464
  ident: CR21
  article-title: Alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes in both normolipidemic and hypertriglyceridemic individuals
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/71.2.458
– volume: 41
  start-page: 453
  year: 2006
  end-page: 461
  ident: CR24
  article-title: Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens
  publication-title: Lipids
  doi: 10.1007/s11745-006-5119-1
– volume: 1031
  start-page: 143
  year: 2004
  end-page: 157
  ident: CR13
  article-title: Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells
  publication-title: AnnN Y Acad Sci
  doi: 10.1196/annals.1331.014
– volume: 342
  start-page: 154
  year: 2000
  end-page: 160
  ident: CR23
  article-title: Vitamin E supplementation and cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200001203420302
– volume: 116
  start-page: 675
  year: 1986
  end-page: 681
  ident: CR2
  article-title: Dietary vitamin E requirement for optimum immune response in the rat
  publication-title: J Nutr
  doi: 10.1093/jn/116.4.675
– volume: 13
  start-page: 55
  year: 1992
  end-page: 74
  ident: CR7
  article-title: Tolerance and safety of vitamin E: a toxicological position report
  publication-title: Free Radic Biol Med
  doi: 10.1016/0891-5849(92)90166-E
– volume: 34
  start-page: 191
  year: 1997
  end-page: 201
  ident: CR10
  article-title: Vitamin E supplementation suppresses prostaglandin E2 synthesis and enhances the immune response of aged mice
  publication-title: Mech Ageing Dev
  doi: 10.1016/0047-6374(86)90034-5
– volume: 7
  start-page: 137
  year: 1992
  end-page: 141
  ident: CR20
  article-title: Vitamin E from Palm Oil; Its Extraction and Nutritional Properties
  publication-title: Lipid Technol
– volume: 49
  start-page: 94
  year: 2003
  end-page: 99
  ident: CR16
  article-title: Effect of vitamin E supplementation on antioxidant defense systems and humoral immune responses in young, middle-aged and elderly Korean women
  publication-title: J Nutr Sci Vitaminol
  doi: 10.3177/jnsv.49.94
– volume: 70
  start-page: 793
  year: 1999
  end-page: 801
  ident: CR22
  article-title: High doses of vitamin E in the treatment of disorders of the central nervous system in the aged
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/70.5.793
– volume: 7
  start-page: 145
  year: 1989
  end-page: 173
  ident: CR12
  article-title: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.07.040189.001045
– volume: 118
  start-page: 235
  year: 1999
  end-page: 241
  ident: CR3
  article-title: Impaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humans
  publication-title: Clin Exp Immunol
  doi: 10.1046/j.1365-2249.1999.01045.x
– volume: 69
  start-page: 1273
  year: 1999
  end-page: 1281
  ident: CR15
  article-title: Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/69.6.1273
– volume: 120
  start-page: 1096
  year: 1990
  end-page: 1102
  ident: CR11
  article-title: High dietary intakes of vitamin E and cellular immune functions in rats
  publication-title: JNutr
– volume: 63
  start-page: 1697
  year: 1999
  end-page: 1702
  ident: CR5
  article-title: Dietary effect of tocopherols and tocotrienols on the immune function of spleen and mesenteric lymph node lymphocytes in Brown Norway rats
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.63.1697
– volume: 40
  start-page: 285
  year: 1980
  end-page: 291
  ident: CR8
  article-title: Cell-mediated and humoral immune response to tetanus vaccinations in onchocerciasis patients
  publication-title: Ann Trop Med Parasitol
– volume: 51
  start-page: S97
  year: 2000
  end-page: 103
  ident: CR14
  article-title: Tocotrienols inhibit growth of ZR-75-1 breast cancer cells
  publication-title: Int J Food Sci Nutr
  doi: 10.1080/096374800111121
– volume: 8
  start-page: 761
  year: 1997
  end-page: 774
  ident: CR4
  article-title: Effect of 3 months vitamin E supplementation on indices of the cellular and humoral immune response in elderly subjects
  publication-title: Br J Nutr
  doi: 10.1079/BJN19970193
– volume: 74
  start-page: 714
  year: 2001
  end-page: 722
  ident: CR6
  article-title: γ-tocopherol, the major form of vitamin E in the US diet, deserves more attention
  publication-title: Am J Clini Nutr
  doi: 10.1093/ajcn/74.6.714
– volume: 7
  start-page: 145
  year: 1989
  ident: BFejcn2010184_CR12
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.07.040189.001045
– volume: 7
  start-page: 137
  year: 1992
  ident: BFejcn2010184_CR20
  publication-title: Lipid Technol
– volume: 21
  start-page: 447
  year: 2000
  ident: BFejcn2010184_CR1
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(00)01699-6
– volume: 275
  start-page: 13049
  year: 2000
  ident: BFejcn2010184_CR18
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.17.13049
– volume: 116
  start-page: 675
  year: 1986
  ident: BFejcn2010184_CR2
  publication-title: J Nutr
  doi: 10.1093/jn/116.4.675
– volume: 34
  start-page: 191
  year: 1997
  ident: BFejcn2010184_CR10
  publication-title: Mech Ageing Dev
  doi: 10.1016/0047-6374(86)90034-5
– volume: 1031
  start-page: 143
  year: 2004
  ident: BFejcn2010184_CR13
  publication-title: AnnN Y Acad Sci
  doi: 10.1196/annals.1331.014
– volume: 25
  start-page: 464
  year: 1987
  ident: BFejcn2010184_CR19
  publication-title: Am J Trop Med Hyg
– volume: 8
  start-page: 761
  year: 1997
  ident: BFejcn2010184_CR4
  publication-title: Br J Nutr
  doi: 10.1079/BJN19970193
– volume: 69
  start-page: 1273
  year: 1999
  ident: BFejcn2010184_CR15
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/69.6.1273
– volume: 118
  start-page: 235
  year: 1999
  ident: BFejcn2010184_CR3
  publication-title: Clin Exp Immunol
  doi: 10.1046/j.1365-2249.1999.01045.x
– volume: 277
  start-page: 1380
  year: 1997
  ident: BFejcn2010184_CR9
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.1997.03540410058031
– volume: 51
  start-page: S97
  year: 2000
  ident: BFejcn2010184_CR14
  publication-title: Int J Food Sci Nutr
  doi: 10.1080/096374800111121
– volume: 70
  start-page: 793
  year: 1999
  ident: BFejcn2010184_CR22
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/70.5.793
– volume: 63
  start-page: 1697
  year: 1999
  ident: BFejcn2010184_CR5
  publication-title: Biosci Biotechnol Biochem
  doi: 10.1271/bbb.63.1697
– volume: 101
  start-page: 810
  year: 2008
  ident: BFejcn2010184_CR17
  publication-title: Br JNutr
– volume: 40
  start-page: 285
  year: 1980
  ident: BFejcn2010184_CR8
  publication-title: Ann Trop Med Parasitol
– volume: 74
  start-page: 714
  year: 2001
  ident: BFejcn2010184_CR6
  publication-title: Am J Clini Nutr
  doi: 10.1093/ajcn/74.6.714
– volume: 120
  start-page: 1096
  year: 1990
  ident: BFejcn2010184_CR11
  publication-title: JNutr
– volume: 342
  start-page: 154
  year: 2000
  ident: BFejcn2010184_CR23
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200001203420302
– volume: 49
  start-page: 94
  year: 2003
  ident: BFejcn2010184_CR16
  publication-title: J Nutr Sci Vitaminol
  doi: 10.3177/jnsv.49.94
– volume: 77
  start-page: 458
  year: 2000
  ident: BFejcn2010184_CR21
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/71.2.458
– volume: 41
  start-page: 453
  year: 2006
  ident: BFejcn2010184_CR24
  publication-title: Lipids
  doi: 10.1007/s11745-006-5119-1
– volume: 13
  start-page: 55
  year: 1992
  ident: BFejcn2010184_CR7
  publication-title: Free Radic Biol Med
  doi: 10.1016/0891-5849(92)90166-E
SSID ssj0014772
Score 2.2369747
Snippet Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The...
Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The...
Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The objective of this study...
Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were randomly assigned to receive either placebo (control group) or...
Background/Objectives:Vitamin E is an essential fat-soluble vitamin that has been shown to induce favorable effects on animal and human immune systems. The...
SourceID proquest
gale
pubmed
pascalfrancis
crossref
springer
fao
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 63
SubjectTerms 692/698/1543/1565
692/700/459/1994
692/700/565/251/1567
Adjuvants, Immunologic - therapeutic use
Adolescent
Adult
Antibodies, Bacterial - blood
Bacterial diseases
Bacterial diseases of the nervous system. Bacterial myositis
Biological and medical sciences
Blood
Clinical Nutrition
Dietary Supplements
Double-Blind Method
Epidemiology
Feeding. Feeding behavior
Female
Follow-Up Studies
Fundamental and applied biological sciences. Psychology
Human bacterial diseases
human nutrition
Humans
Immune response
Immune system
Immunization
immunoglobulin G
Immunoglobulin G - blood
Infectious diseases
Interferon-gamma - immunology
interferons
interleukin-4
Interleukin-4 - immunology
interleukin-6
Interleukin-6 - immunology
Internal Medicine
Medical sciences
Medicine
Medicine & Public Health
Metabolic Diseases
original-article
Properties
Public Health
Tetanus
Tetanus antitoxin
Tetanus Toxoid - administration & dosage
Tetanus Toxoid - immunology
Tocotrienols
Tocotrienols - administration & dosage
Tocotrienols - blood
Tocotrienols - pharmacology
toxoids
Vaccination
Vaccines
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vitamin E
vitamin supplements
women
Young Adult
Title Effects of supplementation with tocotrienol-rich fraction on immune response to tetanus toxoid immunization in normal healthy volunteers
URI https://link.springer.com/article/10.1038/ejcn.2010.184
https://www.ncbi.nlm.nih.gov/pubmed/20859299
https://www.proquest.com/docview/822384786
https://www.proquest.com/docview/822709320
https://www.proquest.com/docview/866247152
https://www.proquest.com/docview/888103361
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: KQ8
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1476-5640
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: ABDBF
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVEBS
  databaseName: EBSCOhost Food Science Source
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20241102
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: A8Z
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/login.aspx?authtype=ip,uid&profile=ehost&defaultdb=fsr
  providerName: EBSCOhost
– providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1476-5640
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: 7X7
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1476-5640
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: BENPR
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1476-5640
  dateEnd: 20171231
  omitProxy: true
  ssIdentifier: ssj0014772
  issn: 0954-3007
  databaseCode: 8C1
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD5auxckhGADFjaKH1B5IVrucR4QKmPThLQKAZX6ZiW2M4pKUtpUYv-An805cZIpolSKqqo5qmwf-_NnnxvAayQZeRRmrp1GXmoHWYA4iBufHcs04U6mkYNQcPLNNLqeBZ_m4fwAbtpYGHKrbDGxBmpVSrojP8eNzEck5dH71S-bikaRcbWtoJE2lRXUuzrD2AAOPUqMNYTDD5fTz186s0IQ19WckFaQOcCJm6Sbjs_P9Q9ZGE8vlwe9TWqQp2UH2A9X6QYHLzdVL3bR0n9MqvVOdfUYHjUUk03MnHgCB7o4guNJgcfrn3dszGqnz_o2_Qisjwtd4W9NetAlm7bZ-Y_hj8lsvGFlzjZU_NM4mtNLRte3rCplSfW4inJpI5x-Z_nahEkwfBYUeKLZ2vjgahRmlUYmut3g19_lQhmJJgyULQpWEH1eMhOZeccIN1HrSE-fwuzq8tvFtd0UbrAlEqbKll4ScUSCQMVRGEuFlCJUSSZj3w8yiYeoEJlWKhNfJQ7SITfimUxknqtU4XEdEe8ZDIuy0CfAuFI81KGXSTz55Wmc-a6vE0llAJSr_dCCt62mhGyymlNxjaWores-F6RYQYoVqFgLxp34yqTz-J_gCapdpLcItWL21SMDL5JhJL--Ba9oLggzHB1CiAml5iMOGlvwppYgjMDGyLQJdcAuUbatnuS4J3lrco3vEjzrCSIIyN7rUW9idp3DRYNn1NCx4LSdqaJBqY3o1pQFrHtL_0yOd4Uut7VI7CDHd_aIRJGHFCf09ohwjkPsR64Fz80quW8gZdhDToRj1i6b-wbuVM2LvV05hQfm2p-eMxhW661-ibyxykYwiOcxfvILd9Qgw1-ZQmyt
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF715wASQtACNS3tHiBcsGp7_XuoUKCtUtpGCBqpt8XeXZegYIfYEeQNeCnejRmv7coi5FbJhyg7suyd3W--8ezMEPISSEbqe4ltxr4Tm27iAg6C4TMDEUehlSjgIJicfDn0ByP3w7V3vUb-NLkweKyywcQKqGUu8Bv5IRgyBkga-m-nP0xsGoXB1aaDRlx3VpBHVYWxOq_jXC1-ggdXHJ0dg7pfOc7pydX7gVk3GTAFGPfSFE7kh7BqXRn4XiAkmD9PRokIGHMTAYTfA1YQi4jJyALTbfthIiKRpjKW4FrC7oT7rpNNl7kR-H6b706GHz-1YQw3qLpHAY3B8IMV1EU-LRYeqm8i0yfL7NDtGMX1NM5bA_FgGhegrFR32VhGg_8J4VaW8fQReVhTWtrXa_AxWVPZFtnuZ-DOf1_QHq0OmVZf77eIcTxWJfxXlyOd0GHTDWCb_NaVlAuap7TAZqP6YDsOUvxcTMtc5Nj_K8snJsD3V5rOdFoGhWuMiS6KzvSZXwXCtFTAfOcF_PyVj6WWqNNO6TijGdL1CdWZoAuKOA2rDOjwEzK6Ex0-JRtZnqkdQkMpQ095TiLA00zjIGE2U5HAtgPSVswzyJtGU1zUVdSxmceEV9F8FnJULEfFclCsQXqt-FSXD_mf4A6oncc3AO189NnBgDKQbyDbzCAHuBa4no4WkXgfSwEi5w0M8rqSQEyChxFxnVoBr4TVvTqSvY7kja5tvkxwryMIoCM6w_udhdm-HGxS8Ik9yyC7zUrlNSoWvN3DBqHtKN4ZD_plKp9XIoEFPoW1QsT3HaBUnrNCJAxhiplvG-SZ3iW3D4gV_YCDwZw12-b2AZeq5vnKVzkg9wZXlxf84mx4vkvu65ADXntko5zN1QvgrGWyXyMDJV_uGoz-As5ypoM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtNAEF21RUJICEEL1LS0-wDhBSu-Xx4QighRSyFCgkh5M_Z6XYKCHRJHkD_gl_g7znhtVxYlb5X8EMUjy_bMnjnjnQtjz0AyMs9NTD32rFh3Egc4CMen-yIOAyOR4CBUnPxh7J1NnHdTd7rD_jS1MJRW2WBiBdRpIegbeR-OzAaSBl4_q7MiPg5Hrxc_dBogRRutzTQNZSEXcvMT0dvq1fkQqn5uWaO3n9-c6fWAAV3AsZe6sEIvgMU6qe-5vkjh-tw0TIRv204iQPZdMIJYhHYaGnDbphckIhRZlsYpwkqsTFx3l92CeEjZhP60jfVMx6_mRoHA0MaD4dftPQ076MtvIlc5ZWbgdNzhbhYXrWu4u4hXUFOm5mtcR4D_2bytfOLoPrtXk1k-UNb3gO3IfJ8dDHIE8t83vMer9NLqu_0-04YzWeK_uhHpnI-bOQAH7LfqobziRcZXNGZUpbTTSU4finlZiIImf-XFXAdwf-XZUhVkcBwzKnGRfKmyfSWEeSnBedcr_PxVzFIlURec8lnOcyLqc65qQDecEBr2BSL8kE1uRIOP2F5e5PKQ8SBNA1e6ViIQY2axn9imLUNBAwdSU9quxl42mopE3T-dxnjMo2of3w4iUmxEio2gWI31WvGFahzyP8FDqD2KLwHq0eSTRVvJoN2g2bbGTskWIvU6WiyKBtQEkNiur7EXlQShEW5GxHVRBR6J-np1JHsdyUvV1fw6weOOIOBGdE6fdAyzfTgsT0TDrqGxo8ZSoxoPV1G7ejXG27N0ZUrxy2WxrkR8A9GEsUXE8yyQKdfaIhIEeMW2Z2rssVolVzdIvfzAvvDOmmVzdYPXqubJ1kc5ZbcBQdH78_HFEbuj9hroOGZ75XItn4KslslJBQucfblpHPoLMkakHQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+supplementation+with+tocotrienol-rich+fraction+on+immune+response+to+tetanus+toxoid+immunization+in+normal+healthy+volunteers&rft.jtitle=European+journal+of+clinical+nutrition&rft.au=Mahalingam%2C+D&rft.au=Radhakrishnan%2C+A.K&rft.au=Amom%2C+Z&rft.au=Ibrahim%2C+N&rft.date=2011-01-01&rft.issn=0954-3007&rft.eissn=1476-5640&rft.volume=65&rft.spage=63&rft.epage=69&rft_id=info:doi/10.1038%2Fejcn.2010.184&rft.externalDocID=US201301925663
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-3007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-3007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-3007&client=summon